http://www.pmlive.com PMLiVE RSS Feed: News RSS en-gb http://www.pmlive.com/__data/assets/thumbnail/0003/70842/feed-icon-28x28.png http://www.pmlive.com http://www.pmlive.com/pharma_news/uk_pharma_launches_legal_challenge_to_nice_plans_1198205 Applies for judicial review of budget impact test

]]> Tue, 11 Jul 2017 17:21:19 +0100 http://www.pmlive.com/pharma_news/uk_pharma_launches_legal_challenge_to_nice_plans_1198205 http://www.pmlive.com/pharma_news/sanofi_to_pay_$750m_for_vaccines-focused_biotech_protein_sciences_1198193 Adds US firm's recombinant-based influenza vaccine to its portfolio

]]> Tue, 11 Jul 2017 17:19:22 +0100 http://www.pmlive.com/pharma_news/sanofi_to_pay_$750m_for_vaccines-focused_biotech_protein_sciences_1198193 http://www.pmlive.com/pharma_news/uk_sepsis_trust_named_communique_charity_of_the_year_1198198 Wins praise from the judges for its HCP engagement

]]> Tue, 11 Jul 2017 12:34:19 +0100 http://www.pmlive.com/pharma_news/uk_sepsis_trust_named_communique_charity_of_the_year_1198198 http://www.pmlive.com/pharma_news/lilly_wins_on_appeal_in_alimta_vitamin_regimen_dispute_1197908 UK Supreme Court rules in its favour over Actavis

]]> Mon, 10 Jul 2017 12:50:01 +0100 http://www.pmlive.com/pharma_news/lilly_wins_on_appeal_in_alimta_vitamin_regimen_dispute_1197908 http://www.pmlive.com/pharma_news/allergan_wins_in-house_team_of_the_year_at_communique_1197903 Faced with seismic change they focused on the business, its customers and people

]]> Mon, 10 Jul 2017 12:46:11 +0100 http://www.pmlive.com/pharma_news/allergan_wins_in-house_team_of_the_year_at_communique_1197903 http://www.pmlive.com/pharma_news/shire_wins_block_of_roche_misinformation_over_emicizumab_1197862 Obtains a preliminary injunction from a German court

]]> Mon, 10 Jul 2017 09:50:04 +0100 http://www.pmlive.com/pharma_news/shire_wins_block_of_roche_misinformation_over_emicizumab_1197862 http://www.pmlive.com/pharma_news/celgene_joins_pd-1_race_via_partnership_with_beigene_1197746 The pharma giant will pay the Chinese firm up to $980m in milestone payments

]]> Sat, 08 Jul 2017 11:44:00 +0100 http://www.pmlive.com/pharma_news/celgene_joins_pd-1_race_via_partnership_with_beigene_1197746 http://www.pmlive.com/pharma_news/bayer_moves_vilaprisan_into_phase_iii_trials_for_uterine_fibroids_1197827 ASTEROID study will investigate safety and efficacy of the novel drug

]]> Fri, 07 Jul 2017 15:51:56 +0100 http://www.pmlive.com/pharma_news/bayer_moves_vilaprisan_into_phase_iii_trials_for_uterine_fibroids_1197827 http://www.pmlive.com/pharma_news/public_affairs_and_policy_prize_at_communique_for_incisive_health_1197818 Agency also picks up accolades for its media, payer and writing work

]]> Fri, 07 Jul 2017 15:09:44 +0100 http://www.pmlive.com/pharma_news/public_affairs_and_policy_prize_at_communique_for_incisive_health_1197818 http://www.pmlive.com/pharma_news/clark_health_wins_small_consultancy_of_the_year_1197813 Communiqué judges praised the agency as ‘authentic’ and ‘trustworthy’

]]> Fri, 07 Jul 2017 14:47:15 +0100 http://www.pmlive.com/pharma_news/clark_health_wins_small_consultancy_of_the_year_1197813 http://www.pmlive.com/pharma_news/untreatable_gonorrhoea_on_the_march_worldwide,_says_who_1197748 Three people with the STI aren’t responding to last-line antibiotics

]]> Fri, 07 Jul 2017 13:40:34 +0100 http://www.pmlive.com/pharma_news/untreatable_gonorrhoea_on_the_march_worldwide,_says_who_1197748 http://www.pmlive.com/pharma_news/90ten_named_communique_consultancy_of_the_year_2017_1197751 Agency's haul at the awards also included Med Ed Consultancy of the Year

]]> Fri, 07 Jul 2017 12:37:42 +0100 http://www.pmlive.com/pharma_news/90ten_named_communique_consultancy_of_the_year_2017_1197751 http://www.pmlive.com/pharma_news/standing_out_in_a_crowd_1196423 Celltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars

]]> Fri, 07 Jul 2017 00:16:37 +0100 http://www.pmlive.com/pharma_news/standing_out_in_a_crowd_1196423 http://www.pmlive.com/pharma_news/fda_halts_third_merck_myeloma_trial_after_patient_deaths_1197713 More patients died on Keytruda combination than those on other treatments

]]> Thu, 06 Jul 2017 15:11:00 +0100 http://www.pmlive.com/pharma_news/fda_halts_third_merck_myeloma_trial_after_patient_deaths_1197713 http://www.pmlive.com/pharma_news/opdivo_tops_yervoy_in_adjuvant_melanoma_trial_1197714 BMS’ nivolumab reduced the recurrence rate of melanoma compared to Yervoy

]]> Thu, 06 Jul 2017 11:49:37 +0100 http://www.pmlive.com/pharma_news/opdivo_tops_yervoy_in_adjuvant_melanoma_trial_1197714